Data / Research funding / Sarcoidosis
Sarcoidosis: 35 NIH awards ($34.3M) to 22 organizations
35 NIH awards ($34.3M) in the NIH spending category Sarcoidosis, to 22 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
35 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,842,777 | April 1, 2022 | March 31, 2027 | KOTH, LAURA L | reporter.nih.gov |
| Comprehensive Proteomic Classifier for the Molecular Characterization of Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,790,619 | August 15, 2021 | July 31, 2025 | BHARGAVA, MANEESH | reporter.nih.gov |
| Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,640,352 | September 1, 2022 | August 31, 2027 | PARDO-VILLAMIZAR, CARLOS A | reporter.nih.gov |
| Molecular Characterization of Progressive Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,384,181 | September 1, 2023 | July 31, 2027 | MAIER, LISA A | reporter.nih.gov |
| T cell Epitope Discovery in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,300,582 | July 5, 2017 | June 30, 2026 | PALMER, BRENT E | reporter.nih.gov |
| Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,651,339 | August 1, 2024 | July 31, 2029 | FAYAD, ZAHI A. | reporter.nih.gov |
| Characterization of European American and African American Sarcoidosis via Immunogenetics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,557,194 | April 1, 2012 | March 31, 2024 | MONTGOMERY, COURTNEY | reporter.nih.gov |
| Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,497,123 | August 1, 2024 | April 30, 2029 | ZHU, HAN | reporter.nih.gov |
| A novel T7 phage display technology to detect sarcoidosis specific antigens | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,324,057 | December 15, 2019 | November 30, 2024 | SAMAVATI, LOBELIA | reporter.nih.gov |
| Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,262,108 | April 1, 2019 | March 31, 2025 | FINGERLIN, TASHA E. | reporter.nih.gov |
| Peptide-based ELISA for laboratory diagnosis of sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $978,191 | September 15, 2025 | August 31, 2028 | LEVIN, ANDREW E. | reporter.nih.gov |
| Using high T-bet-expressing cells and Serum Chemokines as Indicators of Disease Severity in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $899,310 | September 1, 2021 | August 31, 2026 | ARGER, NICHOLAS KOSTANDINOS | reporter.nih.gov |
| Medication Adherence and Clinical Outcomes in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $885,600 | August 26, 2021 | June 30, 2027 | SHARP, MICHELLE | reporter.nih.gov |
| Delineation of the immunobiology of sarcoidosis and characterization of the effects of Janus kinase inhibition | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $861,300 | July 1, 2021 | June 30, 2026 | DAMSKY, WILLIAM | reporter.nih.gov |
| Understanding Sarcoidosis Susceptibility and Disease Burden Through Multi Omics | NIH | National Heart, Lung, and Blood Institute | 2025 | $778,266 | August 1, 2025 | June 30, 2029 | MONTGOMERY, COURTNEY | reporter.nih.gov |
| Integrative Metabolomics of Sarcoidosis Diagnosis and Progression | NIH | National Heart, Lung, and Blood Institute | 2025 | $760,374 | April 1, 2025 | January 31, 2030 | LIAO, SHU-YI | reporter.nih.gov |
| The Role of Residential Bioaerosol Exposure in Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2024 | $751,734 | September 24, 2024 | August 31, 2025 | GERKE, ALICIA | reporter.nih.gov |
| Precision PET attenuation correction for combined PET/MR imaging of cardiac sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $739,466 | August 1, 2025 | May 31, 2030 | BOWEN, SPENCER L. | reporter.nih.gov |
| Inflammatory and Genetic Cardiomyopathies: Metabolic Phenotyping to Guide Diagnosis and Therapy | NIH | National Heart, Lung, and Blood Institute | 2025 | $663,578 | August 15, 2025 | May 31, 2029 | NAZER, BABAK | reporter.nih.gov |
| Improving sarcoidosis patients’ care with a collaboratively developed, patient centered program | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $638,620 | July 15, 2022 | March 31, 2027 | HARPER, LOGAN | reporter.nih.gov |
| MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $439,000 | May 5, 2023 | June 30, 2026 | LIN, NANCY WEIJIUN | reporter.nih.gov |
| Role of Renin-Angiotensin-Aldosterone System during sarcoidosis granuloma formation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $433,125 | November 18, 2022 | October 31, 2025 | CROUSER, ELLIOTT D | reporter.nih.gov |
| Redox Regulation of Sarcoidosis Granulomas and Fibrosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $433,125 | July 2, 2024 | May 31, 2027 | CROUSER, ELLIOTT D | reporter.nih.gov |
| CD8+ T Cell Dysfunction Promotes Sarcoidosis Progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $408,750 | March 15, 2019 | January 31, 2024 | CELADA, LINDSAY JOHANA | reporter.nih.gov |
| Mentoring in Translational Research in Interstitial Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $341,889 | February 15, 2016 | December 31, 2026 | DRAKE, WONDER P. | reporter.nih.gov |
| Innate Lymphoid Cells and Tertiary Lymphoid Structures in Sarcoidosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $300,000 | September 1, 2025 | August 31, 2026 | LEUNG, THOMAS H. | reporter.nih.gov |
| Multi-Omic Characterization of Immune Cells in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $255,750 | August 1, 2024 | July 31, 2026 | MONTGOMERY, COURTNEY | reporter.nih.gov |
| Common and distinct metabolic pathways of pulmonary sarcoidosis phenotypes and endotypes | NIH | National Heart, Lung, and Blood Institute | 2025 | $249,000 | July 1, 2025 | June 30, 2027 | LIAO, SHU-YI | reporter.nih.gov |
| Mentoring in Translational Research in Interstitial Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 | $227,894 | February 15, 2016 | December 31, 2023 | DRAKE, WONDER P. | reporter.nih.gov |
| PLA2R1 Loss-of-Function: A Monogenic Cause of Sarcoidosis in African-Americans in the ACCESS Cohort | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $213,194 | February 1, 2023 | January 31, 2025 | BORZA, DORIN-BOGDAN | reporter.nih.gov |
| Immune Dysregulation in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $209,456 | April 1, 2020 | March 31, 2025 | HUANG, KAI | reporter.nih.gov |
| MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2023 | $182,533 | May 5, 2023 | September 1, 2023 | LIN, NANCY WEIJIUN | reporter.nih.gov |
| Uncovering the Inflammatory-Fibrotic Axis in Pulmonary Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $173,480 | September 20, 2025 | August 31, 2030 | VAGTS, CHRISTEN | reporter.nih.gov |
| Cardiac Magnetic Resonance Imaging Guided Risk Stratification in Cardiac Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $155,000 | August 20, 2021 | July 31, 2023 | SHENOY, CHETAN N | reporter.nih.gov |
| Americas Association of Sarcoidosis and Other Granulomatous Disorders 2024: The Art of Working Together for Progress | NIH | National Heart, Lung, and Blood Institute | 2024 | $50,000 | August 1, 2024 | July 31, 2025 | SHARP, MICHELLE | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco, CA | 2 | $5.7 million | 0 | $0 |
| National Jewish Health | Denver, CO | 5 | $4.8 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 4 | $4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 2 | $2.9 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 3 | $2.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 1 | $2.3 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 1 | $1.7 million | 0 | $0 |
| Stanford University | Stanford, CA | 1 | $1.5 million | 0 | $0 |
| Wayne State University | Detroit, MI | 1 | $1.3 million | 0 | $0 |
| Kephera Diagnostics, LLC | Framingham, MA | 1 | $978,191 | 0 | $0 |
| Ohio State University | Columbus, OH | 2 | $866,250 | 0 | $0 |
| Yale University | New Haven, CT | 1 | $861,300 | 0 | $0 |
| University of Iowa | Iowa City, IA | 1 | $751,734 | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 1 | $739,466 | 0 | $0 |
| University of Washington | Seattle, WA | 1 | $663,578 | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 1 | $638,620 | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 1 | $408,750 | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 2 | $382,936 | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 1 | $341,889 | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 1 | $300,000 | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 1 | $227,894 | 0 | $0 |
| Meharry Medical College | Nashville, TN | 1 | $213,194 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 21 | $10,203,079 | 0 | $0 |
| 2024 | 20 | $8,151,768 | 0 | $0 |
| 2023 | 16 | $5,803,049 | 0 | $0 |
| 2022 | 15 | $6,135,370 | 0 | $0 |
| 2021 | 11 | $3,985,701 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.